Rocket Pharmaceuticals (RCKT) Return on Equity (2016 - 2025)
Historic Return on Equity for Rocket Pharmaceuticals (RCKT) over the last 10 years, with Q3 2025 value amounting to 0.74%.
- Rocket Pharmaceuticals' Return on Equity rose 100.0% to 0.74% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.74%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.56% for FY2024, which is 400.0% down from last year.
- Latest data reveals that Rocket Pharmaceuticals reported Return on Equity of 0.74% as of Q3 2025, which was up 100.0% from 0.69% recorded in Q2 2025.
- In the past 5 years, Rocket Pharmaceuticals' Return on Equity registered a high of 0.31% during Q1 2021, and its lowest value of 0.75% during Q3 2024.
- In the last 5 years, Rocket Pharmaceuticals' Return on Equity had a median value of 0.52% in 2022 and averaged 0.53%.
- Its Return on Equity has fluctuated over the past 5 years, first surged by 200bps in 2021, then plummeted by -2000bps in 2024.
- Over the past 5 years, Rocket Pharmaceuticals' Return on Equity (Quarter) stood at 0.36% in 2021, then crashed by -46bps to 0.52% in 2022, then rose by 4bps to 0.5% in 2023, then tumbled by -36bps to 0.67% in 2024, then fell by -10bps to 0.74% in 2025.
- Its last three reported values are 0.74% in Q3 2025, 0.69% for Q2 2025, and 0.61% during Q1 2025.